When weight and metabolic health change around midlife, it is understandable to wonder whether an emerging treatment might help. That is one reason this MOTS-c paper interests me.
The first detail to keep in view is simple: this was research in mice, not women going through menopause.
What did the researchers do?
Huanyu Lu and colleagues’ paper appeared online on 6 February 2019, before its April issue publication. Researchers gave MOTS-c to female mice whose ovaries had been surgically removed. [1]
The published abstract reports that treatment prevented the associated weight gain and insulin resistance — difficulty responding properly to insulin. It also reduced fat accumulation and inflammation in fat tissue, and supported brown-fat activity.
The work pointed to AMPK, a pathway involved in how cells regulate energy. This summary uses the abstract and key messages; the subscription-only full paper was not assessed here.
Why study mice?
A controlled animal experiment can help researchers explore an idea and decide what to test next. That groundwork is useful.
But surgical removal of ovaries in mice is not a complete version of a woman’s menopause transition. The species, conditions and outcomes are different. A promising biological idea still needs to show worthwhile benefits and acceptable risks in people.
The questions I still have
This study cannot tell us whether MOTS-c helps hot flushes, brain fog or other menopause symptoms. It cannot establish long-term safety in women or show that it can replace menopausal hormone therapy.
I would keep it in the research conversation without making it a reason to change someone’s menopause-care plan.
Wanting an explanation for changes in your body is reasonable, even when the proposed treatment has not answered that question yet.
A way to read the next headline
Was this tested in women or an animal model? Did it measure the thing I am hoping to improve? What human benefit and safety evidence would we need next?
Those questions help me see the possibility without skipping the missing steps.
Read the original source
- Lu and colleagues: MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction ↗Journal of Molecular Medicine · Online 6 February 2019; April 2019 issue · Published abstract and key messages reviewed; full paper not assessed. PubMed record ↗.